Hallucinations and drugs of ingredients of rifampin (a real world drug study)


Summary:

Hallucinations is found among people who take drugs with ingredients of rifampin, especially for people who are male, 60+ old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 14,776 people who have side effects when taking drugs with ingredients of rifampin from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Rifadin, Rifampin, Rimactane.


On Jul, 28, 2026

14,776 people reported to have side effects when taking drugs with ingredients of rifampin.
Among them, 42 people (0.28%) have Hallucinations


What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,894 drugs and 2,727 conditions by eHealthMe. Check the latest studies of Hallucinations.

Number of reports submitted per year:

Could drugs with ingredients of rifampin cause Hallucinations?

Time on drugs with ingredients of rifampin when people have Hallucinations *:

  • < 1 month: 68.18 %
  • 1 - 6 months: 31.82 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hallucinations when taking drugs with ingredients of rifampin *:

  • female: 35 %
  • male: 65 %

Age of people who have Hallucinations when taking drugs with ingredients of rifampin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.5 %
  • 40-49: 7.5 %
  • 50-59: 12.5 %
  • 60+: 77.5 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Endocarditis (inflammation in heart muscle): 5 people, 11.90%
  2. Device Related Infection: 4 people, 9.52%
  3. Infection: 4 people, 9.52%
  4. Abscess (pus): 3 people, 7.14%
  5. Mycobacterium Avium Complex Infection: 3 people, 7.14%
  6. Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 7.14%
  7. Bacterial Infection: 2 people, 4.76%
  8. Bacterial Sepsis: 2 people, 4.76%
  9. Depression: 2 people, 4.76%
  10. Dermatitis Psoriasiform (large white or silver flakes on the skin): 2 people, 4.76%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Cubicin: 6 people, 14.29%
  2. Levaquin: 4 people, 9.52%
  3. Invanz: 4 people, 9.52%
  4. Vancomycin: 4 people, 9.52%
  5. Albuterol: 4 people, 9.52%
  6. Humalog: 4 people, 9.52%
  7. Aspirin: 3 people, 7.14%
  8. Azithromycin: 3 people, 7.14%
  9. Atarax: 2 people, 4.76%
  10. Levofloxacin: 2 people, 4.76%

Other side effects people have besides Hallucinations *:

You may use this to check any potential undetected side effects.

  1. Confusional State: 12 people, 28.57%
  2. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 7 people, 16.67%
  3. Encephalopathy (functioning of the brain is affected by some agent or condition): 5 people, 11.90%
  4. Insomnia (sleeplessness): 5 people, 11.90%
  5. Overdose: 5 people, 11.90%
  6. Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 11.90%
  7. Visual Impairment: 4 people, 9.52%
  8. Fever: 4 people, 9.52%
  9. Fatigue (feeling of tiredness): 4 people, 9.52%
  10. Diarrhea: 4 people, 9.52%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies

Related studies

Drugs with ingredients of rifampin, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on rifampin. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: